Amgen settles with the FTC over $28 billion deal
By Eva Rothenberg, CNN New York (CNN) — The Federal Trade Commission will allow pharmaceutical giant Amgen to move ahead with its acquisition of Horizon Therapeutics, averting a trial set for September. In a news release Friday, the US antitrust regulator said it accepted a proposal from Amgen that would allow the $27.8 billion deal
Continue Reading